支气管、肺动脉成形术治疗中心型非小细胞癌的临床研究  

Bronchial-pulmonary arterial sleeve resection and reconstruction in the treatment of central non-small cell lung cancer

作　　者：邹礼明[1] 潘承欣[1] 姜玉娥[1] 涂秋平 徐业新 

机构地区：[1]广东省中山市博爱医院胸外科,528403 [2]湖北省荆州市胸科医院外科

出　　处：《中国医师进修杂志（外科版）》2006年第5期41-42,70,共3页Chinese Journal of Postgraduates of Medicine

摘　　要：目的探讨支气管、肺动脉成形术治疗中心型非小细胞肺癌的适应证，术中处理及并发症的防治。方法自1987年10月～2004年12月对96例中心型非小细胞肺癌患者实施支气管、肺动脉成形术治疗。分析其临床资料。结果术后并发症发生率为19．8％（19／96），术后30d病死率为3．1％（3／96），术后1、3、5年生存率分别为82．6％（76／91）、57．8％（37／64）和39．1％（18／46）。结论支气管、肺动脉成形术治疗中心型肺癌是可行的，不仅最大限度地保留了肺组织，提高了患者术后生存质量，而且为部分肺功能差的患者提供了切除病变的机会。Ojective To evaluate the indications and surgical procedure of bronchial- pulmonary arterial sleeve resection for patients with centrally located non- small cell lung cancer （NSCLC）, and to prevent oomplications. Methods From October 1987 to December 2004, 96 cases of central NSCLC were treated with bronchial - pulmonary arterial sleeve resection and reconstruction, The results were retrospectively analyzed. Results The complication rate was 19.8% （19/96）, the mortality rate in 30 - day postoperation was 3.1% （3/96）, the overall 1, 3, 5 year survival rates were 82.6 % （76/ 91）, 57.8%（37/64） and 39.1%（18/46） respectively. Conclusion Bronchial-pulmonary arterial sleeve resection and reconstruction in the treatment of patients with central NSCLC can not only maximize preservation of functional pulmonary parenchyma and improve the quality of life, but also provide an opportunity for those patients with poor pulmonary function to receive surgical resection of the tumor.

关 键 词：肺肿瘤 外科治疗 支气管肺动脉成形术 中心型非小细胞癌 

分 类 号：R734.2[医药卫生—肿瘤]